Market Share of Anti-Viral Therapeutics Industry
The anti-viral therapeutics market is moderately competitive. Some of the major players in the anti-viral therapeutics market are AbbVie Inc., GlaxoSmithKline PLC, Bristol-Myers Squibb Company, Johnson & Johnson, Merck and Co. Inc. The anti-viral therapeutics market is a fast-growing market. The major players in the market are adopting organic and inorganic strategies to survive and expand. Moreover, the key players are focusing on increasing US Food and Drug Administration (FDA) approvals and product launches to leverage current and future market opportunities.
Anti-Viral Therapeutics Market Leaders
AbbVie Inc.
Bristol-Myers Squibb Company
Gilead Sciences Inc.
F. Hoffman-La Roche Ltd
Cipla Inc.
*Disclaimer: Major Players sorted in no particular order
